IMAP Statement on hormone therapy for transgender people

This Statement has been prepared by the International Medical Advisory Panel (IMAP) and was approved in October 2015.

This ‘Statement on Hormone Therapy for Transgender People’ complements and builds on earlier IMAP Statements, including ‘Sexual Rights and Sexual Health Services’ and ‘Sexual Health and Rights of Adolescents and Young People’. In the former Statement, IPPF explicitly explored the sexual rights and sexual health of people who are lesbian, gay, bisexual, transgender and intersex, and described how to provide the non‑discriminatory and essential health services required by these populations.